As GLP-1 drugs like Ozempic and Wegovy reshape the weight management conversation, a new kind of consumer is emerging: one navigating both appetite loss and the need for clinical-level nutrition. These aren’t gym-goers chasing macros — they’re patients juggling medication side effects, muscle health, and real-life energy demands. And the supplement aisle hasn’t caught up.
Enter Kate Farms. Best known for its medical nutrition formulas, the newly Danone-backed brand is stepping into the high-protein game — but with a twist: it’s engineered specifically for people on GLP-1 medications. This isn’t a rebrand of a gym shake. It’s a category correction.
Their new High Protein Nutrition Shake blends 25g of organic, plant-based protein with fiber, essential vitamins, and zero sugar — all in a formula designed to be gentle on digestion and allergy-friendly. More importantly, it’s built in direct response to gaps identified by actual GLP-1 users: fatigue, poor intake, and nutritional deficiencies that can derail progress or comfort.
Available in Chocolate and Strawberry and sold D2C, this shake goes beyond better-for-you — it’s purpose-built. And it signals a larger shift in how brands are thinking about personalization. Not just flavor or function, but formulation that aligns with medical journeys.
In a world where wellness has become one-size-fits-none, Kate Farms is betting on precision over mass appeal — a sign that functional beverages are moving from performance to prescription-informed care. The real opportunity? Meeting people where medicine meets lifestyle.
